Curious Encyclopedia | Investment Dilemmas Surrounding Leading Stocks in the Cannabis Industry

When you hear the word 'cannabis,' what comes to mind? But do you truly understand cannabis? Cannabis Through the Ages—'Half Angel, Half Devil' The cannabis plant contains two naturally occurring compounds: tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is a neuroactive substance—and the chief culprit behind cannabis’s classification as a controlled narcotic. In contrast, CBD is non-neuroactive and antagonizes (counteracts) THC, thereby mitigating THC’s neurological effects on the human body; for this reason, CBD is widely applied in medical treatments. Based on THC content, cannabis is divided into industrial hemp and narcotic (recreational) cannabis. In China, industrial hemp is known as 'Han hemp' and boasts broad applications: hemp fiber can be processed into high-end textiles, while hemp seeds serve as food or animal feed. The editor once spotted a cannabis plant in a remote, desolate area—and nearly dialed 110 in panic… Turns out it was just an ordinary plant… Back home, better munch on some hemp seeds to calm your nerves! Now that we’ve gained a somewhat rudimentary understanding of cannabis, let’s introduce today’s protagonist—the U.S.-listed industrial hemp pioneer Tilray. Company Profile Tilray Inc. is a Canadian pharmaceutical company and cannabis producer headquartered in British Columbia, Canada. It is incorporated in the United States and operates in Australia, New Zealand, Germany, and other countries, focusing on the sale and development of medical cannabis. Its product portfolio includes dried cannabis flower and cannabis extracts—such as full-spectrum oils, purified oil drops, and capsules. Tilray pioneered the future of global medical cannabis research, cultivation, processing, and distribution, and owns over 3 million square feet of land dedicated to cannabis cultivation. The company aims to become a leader in Canada’s adult-use cannabis market. Moments of Glory Amid Growth—How a 'Meme Stock' Was Forged July 2018: Tilray listed on the NASDAQ; its stock initially performed unremarkably. August 2018: A string of positive developments triggered explosive stock price growth. September 18, 2018: Three major catalysts occurred simultaneously—most notably, the CEO, in a post-market interview, hinted at imminent collaborations with alcohol and pharmaceutical companies. September 19, 2018: Tilray’s stock experienced extreme volatility—surging up to 93.57% intraday, rising $145, and briefly touching the $300 mark. Its market capitalization surpassed $24 billion for the first time—followed by five circuit-breaker-triggered plunges. Wall Street issued warnings, cautioning that cannabis stocks could become the next bubble after cryptocurrencies. As of yesterday, July 2, 2019, Tilray closed at $47.39. Current Legalization Status In 1988, the United Nations explicitly stipulated that cannabis plants containing less than 0.3% THC may be utilized industrially. In October 2018, Canada legalized recreational cannabis. To date, 34 countries—including Germany, Australia, Israel, and South Korea—have fully legalized medical cannabis; another nine countries—including the UK, France, and New Zealand—permit limited, regulated use of medical cannabis. Overview of the Industrial Hemp Industry After a bumpy, three-steps-forward-two-steps-back path toward legalization, industrial hemp is currently used primarily in fiber-based products and medical applications.

GPLP Investment & Financing: Sino-US Rikun Raised Nearly 200 Million RMB; YouDi Secured Over 100 Million RMB

YouDi Completes Series B Financing Exceeding 100 Million RMB YouDi, a supply-chain platform for recycled automotive parts, announced completion of a Series B financing round exceeding 100 million RMB. This round was led by YUE Capital, with follow-on investment from NIO Capital. It is reported that the funds will primarily support upgrades to remanufacturing technologies, continued expansion of domestic operations, and entry into overseas markets. Hanfeng Technology Completes Over 100-Million-RMB Series B Financing Recently, IoT company Hanfeng Technology announced completion of a Series B financing round exceeding 100 million RMB, led by Walden International, with Haier Capital joining as a new investor. Previously, Hanfeng Technology had secured Series A funding from Jingfeng Mingyuan and Baidu. Sino-US Rikun Raises Nearly 200 Million RMB in Series A+ Financing Sino-US Rikun—a developer of small activating RNA (saRNA) therapeutics—recently completed a Series A+ financing round nearing 200 million RMB. This round was led by SDIC Venture Capital, with participation from multinational pharmaceutical company Eisai (Japan), Lingcheng Venture Capital, Zhongxin Capital, and Xianghe Chengdao. Miraik Completes Nearly 100-Million-RMB Series A Financing Miraik—a provider of home fitness equipment—has completed a Series A financing round nearing 100 million RMB. Investors include Toutou Is Dao Investment Fund and Hougu Investment (financial advisor).

Oil-Dri Corporation of America Estimates – NYSE:ODC

Oct 23, 2026

TradingView provides financial estimates and actuals for Oil-Dri Corporation of America, enabling users to compare reported results with analyst projections across income statements and cash flows.

TradingView

2026-03-25

Oil Dri declares $0.205 dividend

2026-03-25

Oil-Dri Q1 Earnings Decline Year-Over-Year Amid Tough Comparison Pressures

2026-04-03

Oil-Dri Updates Deferred Compensation Plan and Restricted Stock Agreements

2026-04-03

Oil-Dri Corporation of America Insiders Dispose Stock Amid Bearish Signals

2026-04-04

Oil-Dri Corporation Share Price Crosses Above 200-Day Moving Average